EFFICACY OF CHITOSAN NANOPARTICLES LOADED 0.7% TETRACYCLINE ON CLINICAL PARAMETERS AND PLATELET-DERIVED GROWTH FACTOR-BB IN RAT MODELS
DOI:
https://doi.org/10.22159/ijap.2025.v17s5.03Keywords:
Periodontal disease, Tetracycline, Chitosan nanoparticles, Platelet-derived growth factorAbstract
Objective: Tetracycline is a variety of antibiotic therapy for periodontal disease that has been chemically changed to serve as an antibacterial, anti-collagenase, and anti-inflammatory pharmaceutical, decreasing clinical indicators while increasing PDGF-BB healing factor. Chitosan nanoparticles can be used for drug delivery and have qualities such as delayed, sustainable, more absorption, and resilience drug reveal. The aim of the study is to observe the sub-gingival impact of chitosan nanoparticles loaded with 0.7% tetracycline on clinical parameters and PDGF-BB expression by immunohistochemistry observation.
Methods: In vivo experimental research with a before-after test control group design. 33 rats were enrolled initially, but only 31 completed the study, two samples perished when the observation was performed. The control group received 0.7% tetracycline once daily for 3 and 8 days, as well as placebo gel once daily for the same period. Clinical parameters and PDGF-BB expression were investigated on baseline, 3rd, and 8th day post-intervention with different trials.
Results: The research found that daily tetracycline delivery for 8 d improved clinical measures and raised PDGF-BB expression on 3rd day post-therapy, with significantly analyzed findings (p<0.05). In this study, PDGF-BB expression between all groups after d 3 and 8 wasn’t significantly different (p>0.05). This might be because of the mild severity of periodontitis and shallow pockets in all rat periodontitis model samples.
Conclusion: Scaling by applying chitosan nanoparticles loaded with 0.7% tetracycline every day for 8 d improved clinical measures and enhanced PDGF-BB expression on 3rd day. However, PDGF-BB levels on day 8 did not reach statistical significance.
References
1. Batool H, Nadeem A, Kashif M, Shahzad F, Tahir R, Afzal N. Salivary levels of IL-6 and IL-17 could be an indicator of disease severity in patients with calculus-associated chronic periodontitis. BioMed Res Int. 2018;2018:8531961. doi: 10.1155/2018/8531961, PMID 29670909.
2. Lang NP, Bartold PM. Periodontal health. J Clin Periodontol. 2018;45(Suppl 20):S9-16. doi: 10.1111/jcpe.12936, PMID 29926485.
3. Shyu KG, Choy CS, Wang DC, Huang WC, Chen SY, Chen CH. Change of scaling-induced proinflammatory cytokine on the clinical efficacy of periodontitis treatment. Scientific World Journal. 2015;2015:289647. doi: 10.1155/2015/289647, PMID 25884025.
4. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. doi: 10.1038/nrdp.2017.38, PMID 28805207.
5. Sanz I, Alonso B, Carasol M, Herrera D, Sanz M. Nonsurgical treatment of periodontitis. J Evid Based Dent Pract. 2012;12(3 Suppl):76-86. doi: 10.1016/S1532-3382(12)70019-2, PMID 23040340.
6. Patianna GP, Valente NA. The adjunctive use of locally delivered tetracyclines in periodontal therapy: a narrative review of the recent literature. IDJAR. 2015;1(1):1-4. doi: 10.15713/ins.idmjar.14.
7. Sinha S, Kumar S, Dagli N, Dagli RJ. Effect of tetracycline HCl in the treatment of chronic periodontitis a clinical study. J Int Soc Prev Community Dent. 2014;4(3):149-53. doi: 10.4103/2231-0762.142011, PMID 25374831.
8. Pradnyani IG. Tetracycline HCl gel 0.7% increases the number of fibroblast cells and thickens the periodontal ligament in the gingival sulcus of rats with periodontitis. Intisari Med Sci. 2017;8(1):14-8. doi: 10.15562/ism. v8i1.3.
9. Sachdeva S, Agarwal V. Evaluation of commercially available biodegradable tetracycline fiber therapy in chronic periodontitis. J Indian Soc Periodontol. 2011;15(2):130-4. doi: 10.4103/0972-124X.84381, PMID 21976836.
10. Popa L, Ghica MV, Pirvu CD. Periodontal chitosan-gels designed for improved local intra-pocket drug delivery. Farmacia. 2013;61(2):240-50.
11. Susanto C, Ervina I, Agusnar H. In vitro evaluation of antimicrobial effectiveness chitosan-based tetracycline gel on some pathogenic periodontal bacteria. Int J Appl Dent Sci. 2017;3(2B):71–6.
12. Andrew A, Ervina I, Agusnar H. In vitro chitosan hydrogel-based tetracycline cytotoxicity test on fibroblast viability. In: Proceedings of the 11th International Dentistry Scientific Meeting (IDSM 2017). Paris, France: Atlantis Press; 2018. p. 265-72. doi: 10.2991/idsm-17.2018.36.
13. Ervina I, Wilson AWD, Amalia M, Syahputra A, Nasution AH, Agusnar H. The role of scaling-root Planing with a subgingival application of tetracycline 0,7 % based chitosan hydrogel in periodontitis rats’ model (evaluation of clinical parameters and fibroblast cell counts on periodontal ligaments). Nat Volatiles Essent Oils. 2021;8(4):2315-24.
14. El Alfy EA, El Bisi MK, Taha GM, Ibrahim HM. Preparation of biocompatible chitosan nanoparticles loaded by tetracycline, gentamycin and ciprofloxacin as novel drug delivery system for improvement the antibacterial properties of cellulose-based fabrics. Int J Biol Macromol. 2020;161:1247-60. doi: 10.1016/j.ijbiomac.2020.06.118, PMID 32553963.
15. Raja S, Byakod G, Pudakalkatti P. Growth factors in periodontal regeneration. Int J Dent Hyg. 2009;7(2):82-9. doi: 10.1111/j.1601-5037.2009.00380.x, PMID 19413545.
16. Budi HS, Soesilowati P, Imanina Z. Histopathological description of tooth extraction wound healing in macrophages and neovasculature by administering Ambon banana stem sap. Ind Dent Mag. 2017;3(3):121-7. doi: 10.22146/majkedgiind.17454.
17. Mumford JH, Carnes DL, Cochran DL, Oates TW. The effects of platelet-derived growth factor-BB on periodontal cells in an in vitro wound model. J Periodontol. 2001;72(3):331-40. doi: 10.1902/jop.2001.72.3.331, PMID 11327060.
18. Silvia EI, Amalia M, Nasution EE, Agusnar H, Wulandari P, Nasution RO. Efficacy of chitosan nanoparticle loaded with 0.7% tetracyclines on clinical parameters and fibroblast growth factor-2 in periodontitis models. Int J Appl Pharm. 2024;16(2):1-8. doi: 10.22159/ijap.2024.v16s2.10.
19. Astuti WD, Ervina I, Wilson, Amalia M, Syahputra A, Nasution RO. Effectiveness of chitosan-loaded tetracycline in periodontitis-induced rats. Int J App Pharm. 2024;16(2):64-8. doi: 10.22159/ijap.2024.v16s2.14.
20. Wulandari P, Satria D, Amalia M, Budi SM. Effectiveness freeze dried platelet rich plasma combination of hyaluronic acid after periodontal surgical healing: an experimental study on animal model. Braz Dent Sci. 2023;26(2):1-8. doi: 10.4322/bds.2023.
21. Sharma NK, Prasad A. Evaluation of efficacy of tetracycline as a local drug delivery system in the treatment of chronic periodontitis as an adjunct to scaling and root planning a clinical and microbiological study. IJCMR. 2017;5(4):998-1000.
22. Babrawala IS, Prabhuji ML, Karthikeyan BV, Khanna D. A novel approach using natural 1% (W/W) chitosan as a local drug delivery system in the management of non-surgical periodontal treatment: a pilot study. JIAP. 2016;18(4):129-32.
23. Natalina SI, Yuniarti. The effect of single irrigation with 10% tetracycline HCL solution after scaling and root planing on clinical changes in chronic periodontitis with 4-6 mm pockets. JKGUI. 2003;10(2):585-90. doi: 10.14693/jdi.v10i2.487.
24. Amalia M, Ervina I, Silvia NEE. Antimicrobial activity of chitosan nanoparticles loaded with 0.7% tetracycline against porphyromonas gingivalis. J Dentomaxillofac Sci. 2023;8(3):169-72. doi: 10.15562/jdmfs.v8i3.1652.
25. Alzahrani AS. Gingival crevicular fluid release profile of vascular endothelial cell growth factor and platelet-derived growth factors-BB following minimally invasive flap reflection during treatment of intrabony defects: a randomized clinical trial. J Int Acad Periodontol. 2017;20(1):3-11. PMID 31473715.
26. Joshi AA, Padhye AM, Gupta HS. Platelet-derived growth factor-BB levels in gingival crevicular fluid of localized intrabony defect sites treated with platelet-rich fibrin membrane or collagen membrane containing recombinant human platelet-derived growth factor-BB: a randomized clinical and biochemical study. J Periodontol. 2019;90(7):701-8. doi: 10.1002/JPER.18-0496, PMID 30637748.
27. Avriyanti Hanafiah O, Poravi R, Angga D, Abidin T, Ilyas S, Nainggolan M. The role of TGF beta 1 and PDGF BB in wound healing of the palate. In: Proceedings of the International Dental Conference of Sumatera Utara 2017 (IDCSU 2017). Paris, France: Atlantis Press; 2018. p. 219-25. doi: 10.2991/idcsu-17.2018.57.
28. Kataria S, Chandrashekar KT, Mishra R, Tripathi V, Galav A, Sthapak U. Effect of tetracycline HCl (periodontal plus AB) on Aggregatibacter actinomycetemcomitans levels in chronic periodontitis. Oral Biol Dent. 2015;3(1):2. doi: 10.7243/2053-5775-3-2.
29. De Jesus G, Marques L, Vale N, Mendes RA. The effects of chitosan on the healing process of oral mucosa: an observational cohort feasibility split-mouth study. Nanomaterials (Basel). 2023;13(4):706. doi: 10.3390/nano13040706, PMID 36839074.
Published
How to Cite
Issue
Section
Copyright (c) 2025 ERDI EFFENDI NASUTION, IRMA ERVINA, MARTINA AMALIA, HARRY AGUSNAR, DENNY SATRIA
This work is licensed under a Creative Commons Attribution 4.0 International License.
